Prof. Dr. Falk Nimmerjahn

Lehrstuhl für Genetik

Releasing the brakes: targeting FcγRIIB on B cells to enhance antibody-dependent lymphoma immunotherapy. (2015) Seeling M, Nimmerjahn F Journal article, other Effects of intravenous immunoglobulins on mice with experimental epidermolysis bullosa acquisita. (2015) Hirose M, Tiburzy B, Ishii N, Pipi E, Wende S, Rentz E, Nimmerjahn F, et al. Journal article Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss. (2015) Harre U, Lang S, Pfeifle R, Rombouts Y, Frühbeißer S, Amara K, Bang H, et al. Journal article Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity. (2015) Washburn N, Schwab I, Ortiz D, Bhatnagar N, Lansing JC, Medeiros A, Tyler S, et al. Journal article Intravenous immunoglobulin in neurology--mode of action and clinical efficacy. (2015) Luenemann JD, Nimmerjahn F, Dalakas MC Journal article, Review article Suppression of Fcγ-receptor-mediated antibody effector function during persistent viral infection. (2015) Yamada DH, Elsaesser H, Lux A, Timmerman JM, Morrison SL, De La Torre JC, Nimmerjahn F, Brooks DG Journal article No need for constant help: human IgG2 antibodies have an autonomous agonistic activity for immunotherapy of cancer. (2015) Lux A, Nimmerjahn F Journal article Three blocks are not enough-Blocking of the murine IgG receptor FcγRIV is crucial for proper characterization of cells by FACS analysis (2015) Biburger M, Trenkwald I, Nimmerjahn F Journal article, Note bIgG time for large eaters: Monocytes and macrophages as effector and target cells of antibody-mediated immune activation and repression (2015) Gordan S, Biburger M, Nimmerjahn F Journal article, Review article Sweet and sour: the role of glycosylation for the anti-inflammatory activity of immunoglobulin G. (2014) Kao D, Böhm S, Nimmerjahn F Journal article, Review article